Iridocyclitis
Showing 1 - 25 of 206
Chinese Spondyloarthritis Inception Cohort (CESPIC)
Not yet recruiting
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
- +6 more
- (no location specified)
Jul 25, 2023
Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)
Recruiting
- Cytomegalovirus Anterior Uveitis
- Valganciclovir Hydrochloride
- +3 more
-
San Francisco, CaliforniaProctor Foundation, UCSF
Jul 1, 2022
Non-infectious Anterior Uveitis Trial in Palisades Park, San Antonio (TRS01 eye drops)
Completed
- Non-infectious Anterior Uveitis
- TRS01 eye drops
-
Palisades Park, New Jersey
- +1 more
Aug 20, 2021
German Spondyloarthritis Inception Cohort
Recruiting
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
- +5 more
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Oct 5, 2021
Pathogen Detection in Infectious Uveitis
Recruiting
- Infectious Panuveitis
- Infectious Iridocyclitis
-
Shanghai, ChinaXinhua Hospital
Aug 20, 2020
Retinal Nerve Fiber Layer Thickness During Uncomplicated
Completed
- Anterior Uveitis
- Intermediate Uveitis
-
Québec, CanadaCentre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement
Jan 25, 2021
Cytomegalovirus Infections Trial in Singapore (2% guttae ganciclovir)
Recruiting
- Cytomegalovirus Infections
- 2% guttae ganciclovir
-
Singapore, SingaporeSingapore National Eye Centre
Oct 20, 2020
Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU) Trial in Worldwide (Certolizumab Pegol)
Completed
- Axial Spondyloarthritis (axSpA)
- Anterior Uveitis (AU)
- Certolizumab Pegol
-
Brno, Czechia
- +22 more
Jan 20, 2021
Uveitis, Anterior Trial (Antitubercular treatment (RIFATER ©), Ethambutol, RIFINAH ©)
Not yet recruiting
- Uveitis, Anterior
- Antitubercular treatment (RIFATER ©)
- +2 more
- (no location specified)
Oct 4, 2019
Intra and Extra Intestinal Microbiome in Non-infectious Uveitis
Unknown status
- Autoimmune Uveitis
- +7 more
-
Jakarta Pusat, Jakarta, IndonesiaRSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)
Oct 15, 2019
Non-infectious Anterior Uveitis Trial in United States (ADX-102 Ophthalmic Solution (0.5%), Vehicle of ADX-102 Ophthalmic
Completed
- Non-infectious Anterior Uveitis
- ADX-102 Ophthalmic Solution (0.5%)
- Vehicle of ADX-102 Ophthalmic Solution
-
Birmingham, Alabama
- +26 more
May 15, 2020
Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg
Withdrawn
- Herpes Simplex Virus Keratitis
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
-
New York, New YorkNew York University School of Medicine
Dec 29, 2021
Melanoma Trial in Aurora (VESANOID, Ipilimumab)
Active, not recruiting
- Melanoma
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 7, 2022
Cataract Diabetic, Macula Edema Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)
Not yet recruiting
- Cataract Diabetic
- Macula Edema
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
- (no location specified)
Jul 15, 2021
Uveitis Trial in Saint Louis (Acthar)
Terminated
- Uveitis
-
Saint Louis, MissouriWashington University in St. Louis
Sep 25, 2018
Vogt Koyanagi Harada Disease Trial in São Paulo (Early high-dose corticosteroid and immunosuppressive therapy)
Recruiting
- Vogt Koyanagi Harada Disease
- Early high-dose corticosteroid and immunosuppressive therapy
-
São Paulo, SP, BrazilHospital das Clinicas HCFMUSP, Faculdade de Medicina Universidad
Jan 4, 2022
Achromatopsia Trial in Ann Arbor, London (adeno-associated virus vector AAV- CNGA3)
Completed
- Achromatopsia
- adeno-associated virus vector AAV- CNGA3
-
Ann Arbor, Michigan
- +1 more
Feb 10, 2022
Non-infectious Anterior Uveitis Trial in United States (NS2, Prednisolone acetate ophthalmic suspension (1%))
Completed
- Non-infectious Anterior Uveitis
- NS2
- Prednisolone acetate ophthalmic suspension (1%)
-
Lancaster, California
- +14 more
Mar 8, 2019
Efficacy and Tolerability of Xalatan in Patients
Completed
- Glaucoma
- Ocular Hypertension
- Xalatan 0.005% eye drops
-
Alexandria, Egypt
- +2 more
Feb 1, 2021
Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)
Completed
- Diabetic Macular Edema
- Retina Vein Occlusion
-
Phoenix, Arizona
- +5 more
Nov 18, 2021
X-linked Retinoschisis Trial in United States (rAAV2tYF-CB-hRS1)
Active, not recruiting
- X-linked Retinoschisis
- rAAV2tYF-CB-hRS1
-
San Francisco, California
- +8 more
Jul 18, 2022
Acute Anterior Uveitis Trial (LME636 60 mg/mL ophthalmic solution, Dexamethasone 0.1% ophthalmic solution, LME636 Vehicle)
Completed
- Acute Anterior Uveitis
- LME636 60 mg/mL ophthalmic solution
- +2 more
- (no location specified)
May 31, 2018
Anterior Uveitis Trial in Norfolk (Dexamethasone Phosphate Ophthalmic Solution, Prednisolone Acetate Ophthalmic (1%))
Completed
- Anterior Uveitis
- Dexamethasone Phosphate Ophthalmic Solution
- Prednisolone Acetate Ophthalmic (1%)
-
Norfolk, VirginiaVirginia Eye Consultants
Jul 24, 2018
Ocular Disease Requiring Surgery Trial in Paso Robles, San Luis Obispo, Santa Maria (DEXTENZA®)
Not yet recruiting
- Ocular Disease Requiring Surgery
-
Paso Robles, California
- +2 more
Jan 28, 2021